Beta-Catenin Inhibitors and Degraders
(LBR License revocation underway Jan 2025)
US Application 63/564,573
Filed on 2024-03-13
Filed on 2024-03-13
Beta-Catenin Inhibitors and Degraders
OXYNITIDINE DERIVATIVES USEFUL AS TYROSYL-DNA PHOSPHODIESTERASE INHIBITORS AND RADIOSENSITIZERS
US Application 63/674,198
Filed on 2024-07-22
Filed on 2024-07-22
T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53
Hong Kong
62024096322.8
Filed on 2024-09-03
62024096322.8
Filed on 2024-09-03
METHODS TO IDENTIFY AND SELECTIVELY EXPAND TUMOR ANTIGEN-SPECIFIC
T CELLS .
US Application 63/572,693
Filed on 2024-04-01
Filed on 2024-04-01
RADIOLABELED GLYPICAN-3 (GPC3)-SPECIFIC SINGLE DOMAIN ANTIBODY AND USE THEREOF AS AN IMAGING AGENT FOR DETECTION OF GPC3-POSITIVE TUMORS
US Application 63/570,344
Filed on 2024-03-27
Filed on 2024-03-27
TREATMENT OF CARDIOVASCULAR DISEASE WITH TEM8 ANTIBODIES
US Application 63/557,175
Filed on 2024-02-23
Filed on 2024-02-23
ACYLOXYACYL HYDROLASE AND METHODS OF USE
US Application 63/717,036
Filed on 2024-11-06
Filed on 2024-11-06
METHODS OF DETECTING LOSS OF HETEROZYGOSITY AND DAMAGING MUTATIONS IN IMMUNERELATED GENES IN LIQUID BIOPSIES
US Application 63/572,760
Filed on 2024-04-01
Filed on 2024-04-01
T CELL RECEPTORS TARGETING E545K OR N345K MUTATION IN PIK3CA
US Application 63/565,764
Filed on 2024-03-15
Filed on 2024-03-15